SEC Form D · filed October 28, 2022
PROVECTUS BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Eric Wachter · Knoxville, TNExecDominic Rodrigues · Knoxville, TNDirectorJohn Lacey, Iii · Knoxville, TNDirectorHeather Raines · Knoxville, TNExecWebster Bailey · Knoxville, TNDirectorEd Pershing · Knoxville, TNDirectorAdam Devita · New York, NYDirectorEric Nijensohn · Hinsdale, ILDirectorWinter Richards · Santa Monica, CAExecNeil Underwood · New York, NYExecPaolo Bertolotti · New York, NYDirectorBruce Horowitz · Knoxville, TNExec · DirectorJacob Whitney · Loveland, CODirectorMia Lewin · Sammamish, WAExecAndrew P. Jacobson · Miami, FLDirectorStanley Beckley · Miami, FLDirectorJohn Delta · Miami, FLExecEd Pershing · Knoxville, TNDirectorBruce Horowitz · Knoxville, TNExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗